Clinical Trial Results: A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib [Phase 2]

View source ↗

Summary

Phase 2b trial evaluating Modified Vaccinia Virus in patients with advanced hepatocellular carcinoma who progressed on sorafenib has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Modified Vaccinia Virus (modified vaccinia virus)

Snippet

Sponsor: Jennerex Biotherapeutics | Conditions: Hepatocellular Carcinoma, Liver Cancer | Phase 2 | Status: COMPLETED | Results posted: 2026-07-08